- #389 Nityananda Reddy & family ₹9,600 Cr

About Lyfius Pharma Private Limited
Data last updated:
Lyfius Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Aurobindo Antibiotics Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 November 2020 and has been in existence for over 6 years.
Its director Nityananda Reddy and family are #389 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24299AP2020PTC116443. Its GSTIN is 37AAECL4415B1ZX (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Medisetti Venkata Ramakrishna (Whole-Time Director) and Santhanam Subramanian.
Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.95 Lakh. For the same year it recorded a net loss of ₹11.19 Cr and EBITDA of -₹40.78 Lakh.
The company has about 962 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1,550 Cr and satisfied charges of ₹700 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending.
For more details, the company can be reached via its website aurobindo.com.
Company details
Recognitions & Rankings of Lyfius Pharma
Contact details
Lyfius Pharma Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered AddressUnit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lyfius Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lyfius Pharma Private Limited
FY 2025 filings availableLyfius Pharma Private Limited reported revenue of ₹1.95 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹1.95 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹40.78 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹11.19 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Lyfius Pharma Private Limited, buy the company report.
Board of directors of Lyfius Pharma Private Limited
Lyfius Pharma has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Medisetti Venkata Ramakrishna Also directs: Qule Pharma Private Limited | Whole-Time Director | 25 Apr 2022 | 4 Years 6 Months | Current |
| Santhanam Subramanian Also directs: Apitoria Pharma Private Limited, Qule Pharma Private Limited, Engenra Biologics Private Limited and 5 more | Director | 16 Nov 2020 | 6 Years 0 Months | Current |
| Bala Subramanyam Sami Reddy Palle Reddy Also directs: Qule Pharma Private Limited, Ecophyto Labs LLP | Additional Director | 14 Nov 2025 | 1 Years 0 Months | Current |
| Nityananda Reddy Kambam Also directs: Aurobindo Pharma Ltd, Aurobindo Antibiotics Private Limited, Apl Healthcare Limited and 5 more | Director | 01 Dec 2023 | 2 Years 11 Months | Current |
| Srinivasa Ramachandra Rao Ilapakurthy Also directs: GLS Pharma Limited, Auro Pharma Limited | Director | 30 Jan 2024 | 2 Years 9 Months | Current |
Auditor
Lyfius Pharma Private Limited is audited by G P M & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G P M & ASSOCIATES | FY 2023 | 015343S |
Shareholding
The shareholding of Lyfius Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Lyfius Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2024 | 100988719 | Yes Bank Limited | ₹150 Cr | Open | |
| 31 Jul 2024 | 100957346 | Hdfc Bank Limited | ₹150 Cr | Open | |
| 30 Dec 2022 | 100672468 | Others | ₹1,250 Cr | Open | |
| 04 Nov 2024 | 101020599 | State Bank of India | ₹450 Cr | Satisfied | |
| 15 Jul 2022 | 100593791 | Hdfc Bank Limited | ₹250 Cr | Satisfied |
To see the full charge records of Lyfius Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Lyfius Pharma Private Limited has 4 court cases on record: 3 filed by Lyfius Pharma, 1 filed against it. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 1 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd. and 1 other | Disposed |
| High Court, TAMIL NADU | Original application | Filed against the company by M/S.Lvk Properties Private Limited | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Andhra Pradesh and 4 others | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Andhra Pradesh and 2 others | Disposed |
To see the full case history of Lyfius Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Lyfius Pharma Private Limited has 6 MSME Form 1 returns on record between 2022 and 2024, listing 116 overdue payments to 47 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 47)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Trinitech Infrastructure (India) Private Limited | |||
| an individual supplier | |||
| Vinair Systems Private Limited | |||
| Biolaxi Enzymes Private Limited | |||
| CK Enterprises LLP |
To see the full MSME payment records of Lyfius Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lyfius Pharma Private Limited has a workforce of 962 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 962 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Lyfius Pharma Private Limited, buy the company report.
GST
Lyfius Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAECL4415B1ZX | Andhra Pradesh | Active | 07 Jun 2021 |
To see the full GST registrations and return filing status of Lyfius Pharma Private Limited, buy the company report.
Recent activity
Lyfius Pharma Private Limited has 9 board changes on record since 2020: 7 appointments and 2 cessations. The latest: Bala Subramanyam Sami Reddy Palle Reddy was appointed as Additional Director on 14 Nov 2025.
8 earlier events are in the company report.
News
Frequently asked questions
Lyfius Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 November 2020 (6+ years old) and is registered under CIN U24299AP2020PTC116443.
Lyfius Pharma has 5 current directors:
- Medisetti Venkata Ramakrishna - Whole-Time Director
- Santhanam Subramanian - Director
- Bala Subramanyam Sami Reddy Palle Reddy - Additional Director
- Nityananda Reddy Kambam - Director
- Srinivasa Ramachandra Rao Ilapakurthy - Director
The latest financial statements of Lyfius Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Lyfius Pharma is 37AAECL4415B1ZX, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Lyfius Pharma is U24299AP2020PTC116443. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lyfius Pharma has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending.
Lyfius Pharma was incorporated on 16 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Vijayawada.
Bala Subramanyam Sami Reddy Palle Reddy was appointed as Additional Director on 14 Nov 2025. Srinivasa Ramachandra Rao Ilapakurthy was appointed as Director on 30 Jan 2024. Nityananda Reddy Kambam was appointed as Director on 01 Dec 2023. Lyfius Pharma has 9 board changes on record in total.
Lyfius Pharma has 6 MSME Form 1 returns on record between 2022 and 2024, listing 116 overdue payments to 47 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Lyfius Pharma can be reached through the website aurobindo.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The registered office of Lyfius Pharma is at Unit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021.

